Projects funded by the NCN
The role of NPM1 as biomarker of the targeted therapy efficacy in chronic lymphocytic leukemia patients
2021/43/O/NZ5/01885
Keywords:
nucleophosmin biomarker chronic lymphocytic leukemia
Descriptors:
- NZ5_7: Human disease treatment
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Medyczny w Lublinie, Wydział Lekarski
woj. lubelskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM BIS 3 - announced on 2021-09-15
Amount awarded: 497 960 PLN
Project start date (Y-m-d): 2022-05-25
Project end date (Y-m-d): 2025-09-30
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.